- Metformin alleviates chronic obstructive pulmonary disease and cigarette smoke extract-induced glucocorticoid resistance by activating the nuclear factor E2-related factor 2/heme oxygenase-1 signaling pathway
-
Tao F, Zhou Y, Wang M, Wang C, Zhu W, Han Z, Sun N, Wang D
- KMID: 2526729
- Korean J Physiol Pharmacol.
- 2022 Mar;26(2):95-111.
- doi: 10.4196/kjpp.2022.26.2.95
Chronic obstructive pulmonary disease (COPD) is an important healthcare problem worldwide. Often, glucocorticoid (GC) resistance develops during COPD treatment. As a classic hypoglycemic drug, metformin (MET) can be used as... -
- CITED
-
- Close
- SHARE
-
- Close
